Sollis Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

Sollis Therapeutics General Information

Description

Developer of non-steroid and non-opioid analgesics intended to treat pain conditions affecting large numbers of people. The company's drug is an extended-release combination of analgesic and anti-inflammatory medication purpose-built for targeted local delivery for the treatment of sciatica and other neuropathic pain syndromes, enabling healthcare providers to offer proper therapy for pain.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • PO Box 450
  • Hilliard, OH 43026
  • United States
+1 (614)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • PO Box 450
  • Hilliard, OH 43026
  • United States
+1 (614)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sollis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Jan-2024 Completed Clinical Trials - Phase 3
5. Early Stage VC 25-Mar-2021 Completed Clinical Trials - Phase 3
4. Early Stage VC 25-Aug-2020 Completed Clinical Trials - Phase 3
3. Early Stage VC (Series A) 12-Apr-2018 Completed Clinical Trials - Phase 3
2. Grant 08-Dec-2017 $2M Completed Clinical Trials - Phase 3
1. Corporate 01-Jan-2017 Completed Startup
To view Sollis Therapeutics’s complete valuation and funding history, request access »

Sollis Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1
Series A
To view Sollis Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sollis Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of non-steroid and non-opioid analgesics intended to treat pain conditions affecting large numbers of people.
Drug Discovery
Hilliard, OH
4 As of 2021

Birmingham, AL
 

Salt Lake City, UT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sollis Therapeutics Competitors (17)

One of Sollis Therapeutics’s 17 competitors is Bridge Therapeutics, a Venture Capital-Backed company based in Birmingham, AL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bridge Therapeutics Venture Capital-Backed Birmingham, AL
Phoenix PharmaLabs Venture Capital-Backed Salt Lake City, UT
Semnur Pharmaceuticals Formerly VC-backed Palo Alto, CA
Centrexion Therapeutics Venture Capital-Backed Boston, MA
Pacira BioSciences Formerly VC-backed Tampa, FL
You’re viewing 5 of 17 competitors. Get the full list »

Sollis Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sollis Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cardinal Health Corporation Minority
Medtronic Corporation Minority
The Ohio State University University Minority
Ohio Department of Development Government
Neurotechnology Innovations Translator Corporation Minority
To view Sollis Therapeutics’s complete investors history, request access »

Sollis Therapeutics FAQs

  • When was Sollis Therapeutics founded?

    Sollis Therapeutics was founded in 2017.

  • Where is Sollis Therapeutics headquartered?

    Sollis Therapeutics is headquartered in Hilliard, OH.

  • What is the size of Sollis Therapeutics?

    Sollis Therapeutics has 4 total employees.

  • What industry is Sollis Therapeutics in?

    Sollis Therapeutics’s primary industry is Drug Discovery.

  • Is Sollis Therapeutics a private or public company?

    Sollis Therapeutics is a Private company.

  • What is Sollis Therapeutics’s current revenue?

    The current revenue for Sollis Therapeutics is .

  • How much funding has Sollis Therapeutics raised over time?

    Sollis Therapeutics has raised $54.9M.

  • Who are Sollis Therapeutics’s investors?

    Cardinal Health, Medtronic, The Ohio State University, Ohio Department of Development, and Neurotechnology Innovations Translator have invested in Sollis Therapeutics.

  • Who are Sollis Therapeutics’s competitors?

    Bridge Therapeutics, Phoenix PharmaLabs, Semnur Pharmaceuticals, Centrexion Therapeutics, and Pacira BioSciences are some of the 17 competitors of Sollis Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process